Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria.
about
Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected SubjectsOral bioavailability: issues and solutions via nanoformulations.
P2860
Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Formulation and characterizati ...... y in the treatment of malaria.
@en
Formulation and characterizati ...... y in the treatment of malaria.
@nl
type
label
Formulation and characterizati ...... y in the treatment of malaria.
@en
Formulation and characterizati ...... y in the treatment of malaria.
@nl
prefLabel
Formulation and characterizati ...... y in the treatment of malaria.
@en
Formulation and characterizati ...... y in the treatment of malaria.
@nl
P2093
P2860
P356
P1433
P1476
Formulation and characterizati ...... y in the treatment of malaria.
@en
P2093
Sulabha Pathak
Vandana Patravale
Vivek Borhade
P2860
P304
P356
10.2217/NNM.13.61
P577
2013-08-08T00:00:00Z